These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26950221)

  • 1. Reasons for non-participation in scleroderma support groups.
    Delisle VC; Gumuchian ST; Pelaez S; Malcarne VL; El-Baalbaki G; Körner A; Hudson M; Baron M; Thombs BD;
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):56-62. PubMed ID: 26950221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for Not Participating in Scleroderma Patient Support Groups: A Cross-Sectional Study.
    Gumuchian ST; Delisle VC; Peláez S; Malcarne VL; El-Baalbaki G; Kwakkenbos L; Jewett LR; Carrier ME; Pépin M; Thombs BD;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):275-283. PubMed ID: 28217869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey.
    Gumuchian ST; Delisle VC; Kwakkenbos L; Pépin M; Carrier ME; Malcarne VL; Peláez S; El-Baalbaki G; Thombs BD;
    Disabil Rehabil; 2019 Apr; 41(8):974-982. PubMed ID: 29254393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support Groups in Scleroderma.
    Rice DB; Thombs BD
    Curr Rheumatol Rep; 2019 Feb; 21(4):9. PubMed ID: 30790067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a partially nested randomized controlled trial to evaluate the effectiveness of the Scleroderma Patient-centered Intervention Network Support Group Leader EDucation (SPIN-SSLED) Program.
    Thombs BD; Aguila K; Dyas L; Carrier ME; Fedoruk C; Horwood L; Cañedo-Ayala M; Sauvé M; Kwakkenbos L; Malcarne VL; El-Baalbaki G; Peláez S; Connolly K; Hudson M; Platt RW;
    Trials; 2019 Dec; 20(1):717. PubMed ID: 31831073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys.
    Kwakkenbos L; Carboni-Jiménez A; Carrier ME; Pépin M; Peláez S; Malcarne VL; El-Baalbaki G; Thombs BD;
    Disabil Rehabil; 2021 May; 43(9):1279-1286. PubMed ID: 31522575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the nominal group technique to identify stakeholder priorities and inform survey development: an example with informal caregivers of people with scleroderma.
    Rice DB; Cañedo-Ayala M; Turner KA; Gumuchian ST; Malcarne VL; Hagedoorn M; Thombs BD;
    BMJ Open; 2018 Mar; 8(3):e019726. PubMed ID: 29500214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training and support needs of scleroderma support group facilitators: the North American Scleroderma Support Group Facilitators Survey.
    Delisle VC; Gumuchian ST; El-Baalbaki G; Körner A; Malcarne VL; Peláez S; Carrier ME; Pépin M; Thombs BD;
    Disabil Rehabil; 2019 Oct; 41(20):2477-2482. PubMed ID: 29696997
    [No Abstract]   [Full Text] [Related]  

  • 9. The educational needs of people with systemic sclerosis: a cross-sectional study using the Dutch version of the Educational Needs Assessment Tool (D-ENAT).
    Schouffoer A; Ndosi ME; Vliet Vlieland TP; Meesters JJ
    Rheumatol Int; 2016 Feb; 36(2):289-94. PubMed ID: 26321625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Sclerosis and Perceptions of Quality in Primary Care.
    Toci AL; Hyer JM; Silver RM; Nietert PJ; Hant FN
    Am J Med Sci; 2016 May; 351(5):447-51. PubMed ID: 27140701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of training and support programs for leaders of illness-based support groups: commentary and updated evidence.
    Turner KA; Rice DB; Carboni-Jiménez A; Boruff J; Thombs BD
    Syst Rev; 2019 Mar; 8(1):67. PubMed ID: 30836989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives.
    Stubbs LA; Ferry AM; Guffey D; Loccke C; Wade EM; Pour P; Ardalan K; Chira P; Ganske IM; Glaser D; Higgins G; Luca N; Moore KF; Sivaraman V; Stewart K; Vasquez-Canizares N; Hunt RD; Maricevich RS; Torok KS; Li SC;
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):39. PubMed ID: 37098622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emotional approach coping and the effects of online peer-led support group participation among patients with breast cancer: a longitudinal study.
    Batenburg A; Das E
    J Med Internet Res; 2014 Nov; 16(11):e256. PubMed ID: 25474819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample.
    Leavens A; Patten SB; Hudson M; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1195-201. PubMed ID: 22438281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey.
    Frantz C; Avouac J; Distler O; Amrouche F; Godard D; Kennedy AT; Connolly K; Varga J; Matucci-Cerinic M; Allanore Y
    Semin Arthritis Rheum; 2016 Aug; 46(1):115-23. PubMed ID: 27132536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
    Reed J; Pope J
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the occupational trajectory of patients with systemic sclerosis: a qualitative study.
    Decuman S; Smith V; Grypdonck M; De Keyser F; Verhaeghe S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S26-30. PubMed ID: 25797634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and strategies for coping with scleroderma: implications for a scleroderma-specific self-management program.
    Milette K; Thombs BD; Maiorino K; Nielson WR; Körner A; Peláez S
    Disabil Rehabil; 2019 Oct; 41(21):2506-2515. PubMed ID: 29741963
    [No Abstract]   [Full Text] [Related]  

  • 19. Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
    Azar M; Rice DB; Kwakkenbos L; Carrier ME; Shrier I; Bartlett SJ; Hudson M; Mouthon L; Poiraudeau S; van den Ende CHM; Johnson SR; Rodriguez Reyna TS; Schouffoer AA; Welling J; Thombs BD;
    Disabil Rehabil; 2018 Aug; 40(17):1997-2003. PubMed ID: 28478701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG).
    Harding S; Khimdas S; Bonner A; Baron M; Pope J;
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S38-43. PubMed ID: 22691207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.